Bia Mac

Bia Mac General Information

Biography

Mr. Bia Mac serves as Chief Technology Officer & Board Member at American Laser Healthcare. In 2011, Mr. Mac was awarded a patent from WIPO for the LLLT medical device and BioEnelongen (BELG) methodology. From 2001 to the present, Mr. Mac has traveled worldwide and was the guest speaker at many different universities and hospitals, speaking about the therapy protocols for lasers in medicine. In 1993, the Beckman Laser Institute in California invited Mr. Mac to be part of a research program in lasers. Mr. Mac has spent two decades of research and development in LLLT. While developing his unparalleled knowledge in energy medicine, Mr. Mac initially led a group of scientists to design laser biomedical equipment to treat worldwide patients. He has trained many doctors worldwide during his career as a medical doctor (Vietnam), scientist, and professor. In the early 1990s, Mr. Mac visited Harvard, MIT, and Boston University with his team from the University of Poly Tech to exchange research at the Physics Department. Mr. Mac has served on the organizing committee for the research reports on lasers in medicine every ten years. He has been a frequent keynote speaker and visiting professor in several international hospitals and medical science conventions and is considered a specialist and medical scholar in the area of paralysis therapy. Mr. Mac has worked with over 50 different universities in the world to exchange scientific knowledge in applied laser physics in medicine while traveling to several countries to conduct research in ten major medical fields applicable to his LLLT applications. Among those countries and regions are the United States, Europe, South America, Asia, Africa, and Australia. During the last eight years of R&D work, Mr. Mac finalized specific methodologies for treating each medical condition and has successfully demonstrated this in treating patients using his MB-systems that include twenty versions of the device, each dedicated to several medical areas for LLLT therapy, leading to FDA clearance (2004) and international patent approval for the BioEnelongen (BELG) method. Mr. Mac was educated at the Junior Military Academy in Vietnam from 1965 through 1970. He attended medical school from 1971 to 1975 and attended Polytech University in Vietnam from 1991 to 1995. He is a holder of various patents.